Nirmani Yasara

Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia

S. Taylor, D. Higgs, C. Fisher, 2019, Scientific Reports.

Electronic screen device usage and screen time among preschool-attending children in a suburban area of Sri Lanka

S. Mettananda, Nirmani Yasara, Asanka Rathnasiri, 2022, BMC Pediatrics.

Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial

A. Manamperi, S. Mettananda, A. Premawardhena, 2020, BMJ Open.

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia

A. Manamperi, S. Mettananda, A. Premawardhena, 2022, Scientific Reports.

A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic

S. Mettananda, A. Premawardhena, Nirmani Yasara, 2021, Orphanet Journal of Rare Diseases.